Zymeworks

Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult to treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks' suite of…